A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

Clinical trial NCT01517802 · COMPLETED

Trial details

NCT number: NCT01517802
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Metastatic Breast Cancer

Start date: 2012-03-28
Primary completion: 2021-04-22
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.